News

FDA advisers support pediatric studies of three investigational oncology agents

Publish date: December 12, 2014

 

AT AN FDA ADVISORY COMMITTEE MEETING

References

FDA panelists were cleared of potential conflicts.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

AAP nomogram means fewer unnecessary heel sticks for newborns
MDedge Pediatrics
Oncology hospitalist field is small, but growing
MDedge Pediatrics
New ACOG opinions address gynecologic concerns in young cancer patients
MDedge Pediatrics
Fever, E. coli, and abnormal ultrasound predict renal scarring in pediatric UTI
MDedge Pediatrics
FDA advisers want more data on sunscreen safety
MDedge Pediatrics
NHLBI expert panel issues guideline on sickle cell disease
MDedge Pediatrics
NHLBI expert panel issues guidelines on sickle cell disease
MDedge Pediatrics
Blood cultures offer little benefit to children with CAP
MDedge Pediatrics
Sickle cell anemia trial halted because of early success
MDedge Pediatrics
Young adults with ALL have better survival with pediatric regimens
MDedge Pediatrics